AGP Picks
View all

Today on the Internet: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today on the Internet.

Press releases published on October 24, 2026

Global Security & Technology Summit Unveils Program Ahead of December Event
Global Security & Technology Summit Unveils Month-Long Program in Riyadh
Intelligent CNC Machining Trainers: YALONG Precision Milling and Lathe Education Centers
Industrial Automation: YALONG Showcases Worldskills Ready Automation Cells
Turnkey Industry 4.0 Intelligent Manufacturing Trainers: Advanced TVET Solutions from YALONG
Comprehensive Energy Utilization and Intelligent Equipment: YALONG Powers BRICS Skills Competition
Intelligent Refrigeration and Air Conditioning Trainers: Why YALONG Leads HVAC Didactic Technology
Vocational and Engineering Lab Solutions: YALONG Showcases TVET Training Systems at GESS Dubai
Internet of Things (IOT) Trainer: YALONG Showcases Industrial Mechatronics Simulators at Worldskills
Electric Vehicle (EV) Trainers: Why YALONG Leads New Energy Automotive Education
YALONG Automation Training Equipment: Empowering International Luban Workshops Worldwide
YALONG Electronics Training Equipment Selected for Worldskills ASEAN Vocational Competitions
Jeff Pierson Releases 'Battery Revolution: A BizOps Chronicles Novel,' Exploring AI's Role in the Energy Grid
Teck Provides Update on Highland Valley Copper Operations
AI-119 Vulcan Force Solution Targets California's May 2027 Frontier AI Deadline (Veterans First for America)
Eco-Tech Powers Future Living as Chery Enters Globalisation 3.0
2026 National Poppy Campaign launches with a donation “first” … and stunning mural: Don’t forget to Remember
JelluTide Gummies Introduces Jellu Tide Multi-Ingredient Dietary Supplement Formulation
NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma
NANOBIOTIX annonce les résultats complets de l’étude de Phase 1 évaluant JNJ-1900 (NBTXR3) en combinaison avec des inhibiteurs de points de contrôle immunitaires chez des patients atteints de mélanome cutané résistant aux anti-PD-1, en traitement de de…

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Today on the Internet

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.